company background image
WST logo

West Pharmaceutical Services NYSE:WST Voorraadrapport

Laatste prijs

US$311.66

Marktkapitalisatie

US$22.0b

7D

-9.4%

1Y

-11.3%

Bijgewerkt

20 Nov, 2024

Gegevens

Financiële gegevens bedrijf +

West Pharmaceutical Services, Inc.

NYSE:WST Voorraadrapport

Marktkapitalisatie: US$22.0b

WST Overzicht aandelen

West Pharmaceutical Services, Inc. ontwerpt, produceert en verkoopt insluit- en afgiftesystemen voor injecteerbare medicijnen en gezondheidsproducten in Noord- en Zuid-Amerika, Europa, het Midden-Oosten, Afrika en Azië. Meer informatie

Beloningen

Risicoanalyse

WST onze risicocontroles hebben doorstaan.

West Pharmaceutical Services, Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor West Pharmaceutical Services
Historische aandelenkoersen
Huidige aandelenkoersUS$311.66
52 Week HoogtepuntUS$413.70
52 Week LaagUS$265.00
Bèta1
11 maand verandering8.50%
3 maanden verandering3.71%
1 Jaar Verandering-11.25%
33 jaar verandering-28.14%
5 jaar verandering107.44%
Verandering sinds IPO24,373.92%

Recent nieuws en updates

Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?

Nov 15
Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?

West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

Oct 27
West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

Recent updates

Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?

Nov 15
Should You Think About Buying West Pharmaceutical Services, Inc. (NYSE:WST) Now?

West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

Oct 27
West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

West Pharma's Destocking Dilemma: Why Staying On The Sidelines Makes Sense

Oct 11

Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely

Sep 20
Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely

A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

Sep 02
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 28
West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

West Pharmaceutical: Continued Destocking And A High Valuation Post Q2 Results (Rating Maintained)

Jul 25

Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?

Jul 15
Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?

We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt

Jun 27
We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt

Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

May 21
Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry

May 11

West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Mar 30
West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Mar 12
Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Why West Pharma Is Far From Done

Feb 28

West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

Feb 20
West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

West Pharmaceutical Services: Still Too Expensive After The Recent Drop

Feb 20

What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Jan 10
What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

West Pharmaceutical: Great Business, Not So Great Valuation

Jan 08

What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

Dec 18
What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Nov 27
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical Services: The Run Might Be Over

Oct 18

Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Sep 24
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

Aug 22
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics

Aug 08

What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

Jun 26
What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

West Pharmaceutical: Hard To Justify The Price

May 26

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

May 16
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

Mar 20
At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

Feb 28
West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

West Pharmaceutical Q4 2022 Earnings Preview

Feb 15

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Jan 31
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive

Dec 19

West Pharmaceutical declares $0.19 dividend

Dec 13

Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Nov 29
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Rendement voor aandeelhouders

WSTUS Life SciencesUS Markt
7D-9.4%-5.8%-1.0%
1Y-11.3%1.7%30.3%

Rendement versus industrie: WST presteerde slechter dan de US Life Sciences -sector, die het afgelopen jaar een rendement van 1.7 % opleverde.

Rendement versus markt: WST presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.3 % opleverde.

Prijsvolatiliteit

Is WST's price volatile compared to industry and market?
WST volatility
WST Average Weekly Movement6.5%
Life Sciences Industry Average Movement8.8%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Stabiele aandelenkoers: WST heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 6% ) van WST is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
192310,600Eric Greenwww.westpharma.com

West Pharmaceutical Services, Inc. ontwerpt, produceert en verkoopt insluit- en afgiftesystemen voor injecteerbare medicijnen en gezondheidsproducten in Noord- en Zuid-Amerika, Europa, het Midden-Oosten, Afrika en Azië-Pacific. Het bedrijf is actief in twee segmenten, eigen producten en in opdracht gemaakte producten. Het segment Eigen Producten biedt stoppen en afdichtingen voor injecteerbare verpakkingssystemen; onderdelen voor spuiten en cartridges, met inbegrip van aangepaste oplossingen voor de behoeften van injecteerbare medicijntoepassingen, evenals toedieningssystemen die de veilige toediening van geneesmiddelen verbeteren door middel van geavanceerde reconstitutie-, meng- en overbrengingstechnologieën; en folies, coatings, wassen en vision inspectie- en sterilisatieprocessen en -diensten om de kwaliteit van verpakkingsonderdelen te verbeteren.

West Pharmaceutical Services, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van West Pharmaceutical Services zich tot de beurswaarde?
WST fundamentele statistieken
MarktkapitalisatieUS$22.02b
Inkomsten(TTM)US$499.60m
Inkomsten(TTM)US$2.88b

45.2x

Koers/Winstverhouding

7.8x

P/S-verhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
WST resultatenrekening (TTM)
InkomstenUS$2.88b
Kosten van inkomstenUS$1.87b
BrutowinstUS$1.00b
Overige uitgavenUS$503.40m
InkomstenUS$499.60m

Laatst gerapporteerde inkomsten

Sep 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)6.90
Brutomarge34.87%
Nettowinstmarge17.37%
Schuld/Eigen Vermogen Verhouding7.4%

Hoe presteerde WST op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

0.3%

Huidig dividendrendement

12%

Uitbetalingsratio

Betaalt WST een betrouwbaar dividend?

Zie WST dividendgeschiedenis en benchmarks
Wanneer moet je WST kopen om een aanstaand dividend te ontvangen?
West Pharmaceutical Services dividenddata
Ex Dividend DatumNov 13 2024
Betaaldatum dividendNov 20 2024
Dagen tot Ex-dividend9 days
Dagen tot dividendbetaaldatum2 days

Betaalt WST een betrouwbaar dividend?

Zie WST dividendgeschiedenis en benchmarks